Evidence map›Paper›PMID 36446954›Full record

ReviewClinical and translational medicine2022

Genetically encoded tools for in vivo G-protein-coupled receptor agonist detection at cellular resolution.

Kayla E Kroning, Wenjing Wang

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Single-chain fluorescent integrators for mapping G-protein-coupled receptor agonists.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kayla E KroningLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-8488-3485
Wenjing WangLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · US

Funding

New classes of optogenetic and chemogenetic tools with a feedback controlDP2MH132939 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, WENJING · 2022 to 2025
$2.3M
Design of genetically encoded sensors for detecting endogenous opioid peptidesR01DA053200 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Wenjing Wang · 2022 to 2026
$1.7M
A G-protein-coupled receptor-based sensor design platform for high throughput drug screeningF31MH129150 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRONING, KAYLA ELIZABETH · 2022 to 2023
$60k
NIDA NIH HHS R01 DA053200NIMH NIH HHS DP2 MH132939NIMH NIH HHS F31 MH129150
6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) are the most abundant receptor type in the human body and are responsible for regulating many physiological processes, such as sensation, cognition, muscle contraction and metabolism. Further, GPCRs are widely expressed in the brain where their agonists make up a large number of neurotransmitters and neuromodulators. Due to the importance of GPCRs in human physiology, genetically encoded sensors have been engineered to detect GPCR agonists at cellular resolution in vivo. These sensors can be placed into two main categories: those that offer real-time information on the signalling dynamics of GPCR agonists and those that integrate the GPCR agonist signal into a permanent, quantifiable mark that can be used to detect GPCR agonist localisation in a large brain area. In this review, we discuss the various designs of real-time and integration sensors, their advantages and limitations, and some in vivo applications. We also discuss the potential of using real-time and integrator sensors together to identify neuronal circuits affected by endogenous GPCR agonists and perform detailed characterisations of the spatiotemporal dynamics of GPCR agonist release in those circuits. By using these sensors together, the overall knowledge of GPCR-mediated signalling can be expanded.

Indexed as

Receptors, G-Protein-CoupledSignal TransductionBrainCognitionHumansKnowledgeReceptors, G-Protein-Coupledgenetically encoded sensorGPCRneuromodulationneurotransmission

Identifiers

PMID36446954
PMCPMC9708909
OpenAlexW4310368228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.